Page 128 - Access Program News Today

Some 11.6 percent of coronavirus tests in the U.S. were positive in the week through September 23, according to the latest CDC data.

Health officials see Novavax’s protein-based vaccine as a valuable alternative for people who don’t want to take messenger RNA shots from Pfizer and...

Rhode Island Governor Dan McKee joined Rhode Island Department of Health (RIDOH) officials to get his flu shot and encourage everyone 6 months of age and older to get their flu shots to stay as healthy as possible this fall and winter.

Health officials see Novavax's protein-based vaccine as a valuable alternative for people who don't want to take messenger RNA shots from Pfizer and Moderna.

Health officials see Novavax’s protein-based vaccine as a valuable alternative for people who don’t want to take messenger RNA shots from Pfizer and...

COVID-19 vaccine began arriving in mid-September, but some were charged in error. Most shots will be free through private insurance, Medicare or Medicaid or public health agencies.

The Best of Newport, RI. Newport Buzz is the leading News Source for Breaking News, What's New and To-Do in Newport, RI.

(Reuters) -The U.S. Food and Drug Administration said on Tuesday it has authorized an updated version of Novavax's COVID-19 vaccine for emergency use in individuals aged 12 years and older, and the company's shares climbed more than 11%. The Maryland-based company, whose COVID vaccine is its lone marketed product, has adopted cost-cutting measures and is counting on commercial sales of its updated shot to help it stay afloat. The U.S. Centers for Disease Control and Prevention (CDC) ...

Security Bank Corp. (PSE:SECB) announced it has been selected to participate in the “Early Access Program (EAP)” for a pilot project of Microsoft Corp. SECB announced last October 2 that it is one of only two Philippine-based organizations invited to join the program that was rolled out to an initial wave of 600 leading customers

The Food and Drug Administration (FDA) granted emergency use authorization to Novavax’s COVID-19 vaccine on Tuesday, bringing the number of immunizations effective against the current circulating strain up to three. Novavax’s vaccine, a more traditional protein-based shot that differs from the mRNA vaccines that have become commonplace, has been authorized for people 12 years of…